<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02469961</url>
  </required_header>
  <id_info>
    <org_study_id>10/07/VA07</org_study_id>
    <nct_id>NCT02469961</nct_id>
  </id_info>
  <brief_title>Dexmedetomidine vs Propofol TIVA (Total Intravenous Anesthesia) and Interscalene Block</brief_title>
  <acronym>TIVA</acronym>
  <official_title>Dexmedetomidine vs Propofol TIVA and Interscalene Block for Shoulder Surgeries in a Beach Chair Sitting Position</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maimonides Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Maimonides Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The standard hospital procedure calls for the patient to undergo Interscalene block under
      ultrasound with or without nerve stimulation guidance prior to going to operating room (OR).
      The block utilizes a 40 ml mixture of 0.5% Ropivacaine and Lidocaine 1.5%. At this time the
      patient receives preliminary sedation with Midazolam 1mg IV and Fentanyl 50 mcg IV. The
      participant is then brought to the OR and prolonged sedation is initiated, randomly using
      either Dexmedetomidine or Propofol.

      The primary objective of the present study is to use Dexmedetomidine for sedation, and
      compare the outcomes with Propofol sedation. The investigators will enroll 50 patients for
      this study.

      Our hypothesis is that Dexmedetomidine will cause fewer episodes of intermittent apnea, and
      reduced need for supplemental medication for sedation, compared to Propofol
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The anesthesia provided during shoulder surgery commonly uses a combination of regional and
      intravenous (IV) anesthetic medications. The current drug of choice for IV sedation is
      Propofol. Although. it is a good anesthetic, incidence of intermittent apnea makes the use of
      it problematic in cases where the head of the patient is less accessible to the
      anesthesiologist, as is in sitting beach char position. Dexmedetomidine is a FDA approved
      drug, which has a very stable cardiovascular and respiratory profile. It has been
      successfully used for Neurological and Vascular cases and in Intensive care units. The
      primary objective of the present study is to use Dexmedetomidine for sedation, and compare
      the outcomes with Propofol sedation. The investigators' will enroll 50 patients for this
      study. Using a computer program the participants will be randomized into two equal groups to
      receive either Dexmedetomidine or Propofol.

      The standard hospital procedure calls for the patient to undergo Interscalene block under
      ultrasound with or without nerve stimulation guidance prior to going to operating room (OR).
      The block utilizes a 40 ml mixture of 0.5% Ropivacaine and Lidocaine 1.5%. At this time the
      patient receives preliminary sedation with Midazolam 1mg IV and Fentanyl 50 mcg IV. The
      participant is then brought to the OR and prolonged sedation is initiated, randomly using
      either Dexmedetomidine or Propofol.

      Dexmedetomidine infusion is initiated with a bolus of 1 mcg/kg is given over 10 min as
      patient is being positioned, and the sedation is maintained with Dexmedetomidine at 0.7- 1.0
      mcg/kg/hr during the surgery. Propofol infusion is started at 100mcg/kg/min, and maintained
      with Propofol at 50-120mcg/kg/min, during the surgery.

      In each group the investigators will record the incidence of respiratory depression/hypoxia,
      hemodynamic stability, frequency of airway manipulation, cardiovascular effects, need for
      anesthetic supplementation of Dexmedetomidine, post anesthesia care unit (PACU) discharge
      time, the need for postoperative pain medication, post operative complications, like
      nausea/vomiting.

      Significant differences between the two groups will be evaluated using unpaired t-test for
      numerical variables, and Chi-square test or Z test for categorical variables.

      The investigators hypothesis is that Dexmedetomidine will cause fewer episodes of
      intermittent apnea, and reduced need for supplemental medication for sedation, compared to
      Propofol
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2010</start_date>
  <completion_date type="Actual">July 2012</completion_date>
  <primary_completion_date type="Actual">August 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants That Need an Airway Intervention.</measure>
    <time_frame>Participants will be followed from the start of sedation until discharge: approximately 3-5 hr</time_frame>
    <description>airway manipulation or repositioning: apnea, oral airway, adjust head</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Post Anesthesia Care Unit (PACU) Length of Stay</measure>
    <time_frame>Arrival in the PACU until discharge either to home or to a hospital in-patient bed approximately 1-3 hr after the operation</time_frame>
    <description>length of stay in minutes in the Post Anesthesia Care Unit before discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants That Have Either Bradycardia or Hypotension</measure>
    <time_frame>Participants will be followed from the start of sedation until discharge: approximately 3-5 hr</time_frame>
    <description>Number of participants observed with Bradycardia or Hypotension who required intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Narcotic Used by Each Participant</measure>
    <time_frame>Participants will be followed from the start of sedation until discharge: approximately 3-5 hr</time_frame>
    <description>the use for morphine and/or fentanyl and or Demerol converted to morphine equivalents</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Shoulder Pain</condition>
  <arm_group>
    <arm_group_label>dexmedetomidine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive an interscalene block and be sedated with dexmedetomidine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Propofol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will receive an interscalene block and be sedated with propofol</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>Participants will receive an interscalene block and will be sedated with Dexmedetomidine and compared to sedation with propofol</description>
    <arm_group_label>dexmedetomidine</arm_group_label>
    <other_name>precedex</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>Participants will receive an interscalene block and be sedated with Propofol and compared to sedation with Dexmedetomidine</description>
    <arm_group_label>Propofol</arm_group_label>
    <other_name>diprivan</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Interscalene block</intervention_name>
    <description>Interscalene block is used for the main anesthetic for the case</description>
    <arm_group_label>dexmedetomidine</arm_group_label>
    <arm_group_label>Propofol</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Participants scheduled for shoulder arthroscopies in the beach chair sitting position.

        Participants who received a successful interscalene block.

        Exclusion Criteria:

        Failed interscalene block. Refusal to participate in the study. Allergy to the study drugs.
        Participants that need a secure airway.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>piyush Gupta, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maimonides Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Maimonides Medical Center</name>
      <address>
        <city>Brooklyn</city>
        <state>New York</state>
        <zip>11219</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Mehta PP, Kochhar G, Kalra S, Maurer W, Tetzlaff J, Singh G, Lopez R, Sanaka MR, Vargo JJ. Can a validated sleep apnea scoring system predict cardiopulmonary events using propofol sedation for routine EGD or colonoscopy? A prospective cohort study. Gastrointest Endosc. 2014 Mar;79(3):436-44. doi: 10.1016/j.gie.2013.09.022. Epub 2013 Nov 9.</citation>
    <PMID>24219821</PMID>
  </results_reference>
  <results_reference>
    <citation>Venn RM, Hell J, Grounds RM. Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care. Crit Care. 2000;4(5):302-8. Epub 2000 Jul 31.</citation>
    <PMID>11056756</PMID>
  </results_reference>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 3, 2015</study_first_submitted>
  <study_first_submitted_qc>June 9, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 12, 2015</study_first_posted>
  <results_first_submitted>September 15, 2015</results_first_submitted>
  <results_first_submitted_qc>December 30, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">February 1, 2016</results_first_posted>
  <last_update_submitted>March 17, 2016</last_update_submitted>
  <last_update_submitted_qc>March 17, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 15, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Maimonides Medical Center</investigator_affiliation>
    <investigator_full_name>Piyush Gupta, MD</investigator_full_name>
    <investigator_title>Clinical Director</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Shoulder Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Dexmedetomidne</title>
          <description>Participants will receive an interscalene block and be sedated with dexmedetomidine
Dexmedetomidine: Participants will receive an interscalene block and will be sedated with Dexmedetomidine and compared to sedation with propofol
Interscalene block: Interscalene block is used for the main anesthetic for the case</description>
        </group>
        <group group_id="P2">
          <title>Propofol</title>
          <description>Participants will receive an interscalene block and be sedated with propofol
Propofol: Participants will receive an interscalene block and be sedated with Propofol and compared to sedation with Dexmedetomidme
Interscalene block: Interscalene block is used for the main anesthetic for the case</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="25"/>
                <participants group_id="P2" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
                <participants group_id="P2" count="24"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>45</population>
      <group_list>
        <group group_id="B1">
          <title>Dexmedetomidine</title>
          <description>Participants will receive an interscalene block and be sedated with dexmedetomidine
Dexmedetomidine: Participants will receive an interscalene block and will be sedated with Dexmedetomidine and compared to sedation with propofol
Interscalene block: Interscalene block is used for the main anesthetic for the case</description>
        </group>
        <group group_id="B2">
          <title>Propofol</title>
          <description>Participants will receive an interscalene block and be sedated with propofol
Propofol: Participants will receive an interscalene block and be sedated with propofol and compared to sedation with Dexmedetomidine
Interscalene block: Interscalene block is used for the main anesthetic for the case</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="21"/>
            <count group_id="B2" value="24"/>
            <count group_id="B3" value="45"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants That Need an Airway Intervention.</title>
        <description>airway manipulation or repositioning: apnea, oral airway, adjust head</description>
        <time_frame>Participants will be followed from the start of sedation until discharge: approximately 3-5 hr</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Dexmedetomidine</title>
            <description>Number of patients required airway manipulation</description>
          </group>
          <group group_id="O2">
            <title>Propofol</title>
            <description>Number of patients required airway manipulations</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants That Need an Airway Intervention.</title>
          <description>airway manipulation or repositioning: apnea, oral airway, adjust head</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Post Anesthesia Care Unit (PACU) Length of Stay</title>
        <description>length of stay in minutes in the Post Anesthesia Care Unit before discharge</description>
        <time_frame>Arrival in the PACU until discharge either to home or to a hospital in-patient bed approximately 1-3 hr after the operation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Dexmedetomidine</title>
            <description>Participants will receive an interscalene block and be sedated with dexmedetomidine
Dexmedetomidine: Participants will receive an interscalene block and will be sedated with Dexmedetomidine and compared to sedation with propofol
Interscalene block: Interscalene block is used for the main anesthetic for the case</description>
          </group>
          <group group_id="O2">
            <title>Propofol</title>
            <description>Participants will receive an interscalene block and be sedated with propofol
Propofol: Participants will receive an interscalene block and be sedated with Propofol and compared to sedation with Dexmedetomidme
Interscalene block: Interscalene block is used for the main anesthetic for the case</description>
          </group>
        </group_list>
        <measure>
          <title>Post Anesthesia Care Unit (PACU) Length of Stay</title>
          <description>length of stay in minutes in the Post Anesthesia Care Unit before discharge</description>
          <units>Minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="159" spread="12"/>
                    <measurement group_id="O2" value="126" spread="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants That Have Either Bradycardia or Hypotension</title>
        <description>Number of participants observed with Bradycardia or Hypotension who required intervention</description>
        <time_frame>Participants will be followed from the start of sedation until discharge: approximately 3-5 hr</time_frame>
        <population>Number of patients who had Bradycardia or hypotension</population>
        <group_list>
          <group group_id="O1">
            <title>Propofol</title>
            <description>Patients who received Propofol</description>
          </group>
          <group group_id="O2">
            <title>Dexmedetomidine</title>
            <description>Patients who received Dexmedetomidine</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants That Have Either Bradycardia or Hypotension</title>
          <description>Number of participants observed with Bradycardia or Hypotension who required intervention</description>
          <population>Number of patients who had Bradycardia or hypotension</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Total Narcotic Used by Each Participant</title>
        <description>the use for morphine and/or fentanyl and or Demerol converted to morphine equivalents</description>
        <time_frame>Participants will be followed from the start of sedation until discharge: approximately 3-5 hr</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Dexmedetomidine</title>
            <description>Participants will receive an interscalene block and be sedated with dexmedetomidine
Dexmedetomidine: Participants will receive an interscalene block and will be sedated with Dexmedetomidine and compared to sedation with propofol
Interscalene block: Interscalene block is used for the main anesthetic for the case</description>
          </group>
          <group group_id="O2">
            <title>Propofol</title>
            <description>Participants will receive an interscalene block and be sedated with propofol
Propofol: Participants will receive an interscalene block and be sedated with Propofol and compared to sedation with Dexmedetomidine
Interscalene block: Interscalene block is used for the main anesthetic for the case</description>
          </group>
        </group_list>
        <measure>
          <title>Total Narcotic Used by Each Participant</title>
          <description>the use for morphine and/or fentanyl and or Demerol converted to morphine equivalents</description>
          <units>Microgram</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.1" spread="23.9"/>
                    <measurement group_id="O2" value="9" spread="24.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Study was conducted for one year and four months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Dexmedetomidine</title>
          <description>Participants will receive an interscalene block and be sedated with dexmedetomidine
Dexmedetomidine: Participants will receive an interscalene block and will be sedated with Dexmedetomidine and compared to sedation with propofol
Interscalene block: Interscalene block is used for the main anesthetic for the case</description>
        </group>
        <group group_id="E2">
          <title>Propofol</title>
          <description>Participants will receive an interscalene block and be sedated with propofol
Propofol: Participants will receive an interscalene block and be sedated with Propofol and compared to sedation with Dexmedetomidme
Interscalene block: Interscalene block is used for the main anesthetic for the case</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="24"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="24"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>There was no limitations</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Piyush Gupta, Director of clinical affairs</name_or_title>
      <organization>Maimonides Medical Center</organization>
      <phone>718-283-7189</phone>
      <email>pgupta@maimonidesmed.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

